Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty

  • Díaz Ruíz, Raquel|||0000-0002-2259-0289
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Roman, Eva|||0000-0001-9084-8555
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Bañares, Irene
  • Morales, Ángela
  • Hernández Martínez-Esparza, Elvira|||0000-0002-9736-9052
  • Panadero, Rocío
  • Velasco, Cristina
  • Rapado-Castro, Marta|||0000-0001-8484-6051
  • Breton, Irene|||0000-0003-0263-3728
  • Bañares, Rafael|||0000-0002-0412-8437
  • Soriano, German|||0000-0002-9267-6811
  • García Martínez, Rita|||0000-0003-2159-2757
Background/aim : Frailty is increasingly recognized as a relevant prognostic factor in patients with cirrhosis, regardless of liver failure. Vitamin D deficiency is frequent in these patients and has been related to frailty and sarcopenia, but the impact of its supplementation on frailty in cirrhosis is unknown. The aim was to evaluate the effect of vitamin D supplementation on frailty in patients with decompensated cirrhosis and vitamin D deficiency or insufficiency. Methods : We included patients with cirrhosis who had vitamin D deficiency or insufficiency following their hospitalization for acute decompensation. Vitamin D was supplemented according to current recommendations, as were other micronutrients if necessary. Patients were followed for one year to evaluate changes at 6 and 12 months in frailty (Fried frailty index), health-related quality of life (SF-36, CLDQ) and mood (HADS). Body composition was assessed by DXA at baseline and at 12 months. Results : We included 39 patients, 27 of whom reached the 6-month follow-up. Serum vitamin D increased at 6 and 12 months (p < 0.001 compared to baseline). Fried frailty index improved at the 6-month visit (p = 0.004), and handgrip strength improved at 6 (p = 0.001) and 12 (p = 0.002) months, similarly in women and men. At 12 months, we observed an increase in body mass index, right arm lean mass and total fat mass. Conclusions : A multifactorial nutritional intervention, especially vitamin D supplementation after discharge in decompensated, vitamin D-deficient patients with cirrhosis, was associated with an improvement in frailty, muscular strength and lean muscle mass. However, the increase in fat mass strengthens the recommendation for diet, exercise and weight supervision.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis

  • Díaz Ruíz, Raquel|||0000-0002-2259-0289
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Roman, Eva|||0000-0001-9084-8555
  • Panadero, Rocío
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Bañares, Irene
  • Morales, Ángela
  • Puerto, Marta|||0000-0002-1263-9296
  • Lopez-Esteban, Rocio
  • Blazquez, Elena
  • Fernández-Castillo, Marta
  • Correa-Rocha, Rafael|||0000-0003-3456-9986
  • Rapado-Castro, Marta|||0000-0001-8484-6051
  • Breton, Irene|||0000-0003-0263-3728
  • Bañares, Rafael|||0000-0002-0412-8437
  • Soriano, German|||0000-0002-9267-6811
  • García Martínez, Rita|||0000-0003-2159-2757
Background/Objectives: Decompensated cirrhosis is characterized by systemic inflammation and innate and adaptive immune dysfunction. Hepatic encephalopathy (HE) is a prevalent and debilitating condition characterized by cognitive disturbances in which ammonia and inflammation play a synergistic pathogenic role. Extraskeletal functions of vitamin D include immunomodulation, and its deficiency has been implicated in immune dysfunction and different forms of cognitive impairment. The aim was to assess changes in cognitive function and inflammation in decompensated patients with cirrhosis receiving vitamin D supplementation. Methods : Patients with cirrhosis discharged from decompensation in two tertiary hospitals in Spain (from September 2017 to January 2020) were assessed before, at 6 and 12 months after vitamin D supplementation. A comprehensive neuropsychological battery and neuroinflammatory markers were examined. In a subgroup of patients, peripheral immune blood cells were analyzed. Results : Thirty-nine patients were recruited. Of those, 27 completed the 6 months evaluation and were analyzed [age 62.4 ± 11.3 years; 22 men; Model for End-Stage Liver Disease (MELD) 11.7 ± 4.0; prior overt HE 33%; median 25-hydroxyvitamin D (25OHD) plasma level 12.7 µgr/L] and 22 achieved 12 months assessment. At baseline, learning and memory (R = 0.382; p = 0.049) and working memory (R = 0.503; p = 0.047) subtests correlated with plasma 25OHD levels. In addition, processing speed (R = -0.42; p = 0.04), attention (R = -0.48; p = 0.04), Tinnetti balance (R = -0.656; p < 0.001) and Tinnetti score (R = -0.659; p < 0.001) were linked to neuroinflammation marker IL-1β. Patients with lower 25OHD had a greater proportion of TH1cells at baseline and a larger amelioration of IL-1β and IL-6 following supplementation. An improvement in working memory was found after 25OHD replacement (46.7 ± 13 to 50 ± 11; p = 0.047). Conclusions : This study supports that vitamin D supplementation modulates low-grade inflammation in decompensated cirrhosis providing cognitive benefits, particularly in working memory.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue

  • González-Franquesa, A.
  • Gama-Pérez, P.
  • Kulis, M.
  • Szczepanowska, K.
  • Dahdah, N.
  • Moreno-Gómez, S.
  • Latorre Pellicer, A.
  • Fernández-Ruiz, R.
  • Aguilar-Mogas, A.
  • Hoffman, A.
  • Monelli, E.
  • Samino, S.
  • Miró-Blanch, J.
  • Oemer, G.
  • Duran, X.
  • Sánchez-Rebordelo, E.
  • Schneeberger, M.
  • Obach, M.
  • Montane, J.
  • Castellano, G.
  • Chapaprieta, V.
  • Sun, W.
  • Navarro, L.
  • Prieto, I.
  • Castaño, C.
  • Novials, A.
  • Gomis, R.
  • Monsalve, M.
  • Claret, M.
  • Graupera, M.
  • Soria, G.
  • Wolfrum, C.
  • Vendrell, J.
  • Fernández-Veledo, S.
  • Enríquez, J. A.
  • Carracedo, A.
  • Perales, J. C.
  • Nogueiras, R.
  • Herrero, L.
  • Trifunovic, A.
  • Keller, M. A.
  • Yanes, O.
  • Sales-Pardo, M.
  • Guimerà, R.
  • Blüher, M.
  • Martín-Subero, J. I.
  • García-Roves, P.
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Intersectional analysis of social determinants of health and their association with mortality in patients with multimorbidity

  • Moreno-Juste, Aida
  • Laguna-Berna, Clara
  • Poblador-Plou, Beatriz
  • Calderón-Larrañaga, Amaia
  • Librero, Julián
  • Lozano-Hernández, Cristina
  • Santos-Mejías, Alejandro
  • Castillo-Jimena, Marcos
  • Gimeno-Miguel, Antonio
  • Gimeno-Feliú, Luis A
Background We aimed to analyse the association between social determinants of health (SDH) and mortality in patients with multimorbidity from an intersectional point of view. Methods We conducted a retrospective observational study in the EpiChron cohort (Aragon, Spain), including all patients with two or more chronic conditions in 2015, who were followed up until 2020, to analyse all-cause mortality. Logistic regressions models were performed to analyse the likelihood of mortality across 24 intersectional strata defined by gender, migration status/length of stay, residence area and socioeconomic class. The area under the receiver operator characteristics curve was estimated to evaluate the discriminatory accuracy of mortality. Results Nearly one in 10 people with multimorbidity died during the study period. The likelihood of mortality was higher in men, in people with lower annual gross income, and in those living in rural areas. The intersectional analysis showed that low-income migrant men with more than 15 years in Spain and living in rural settings had a 4.2 times higher risk of death than that observed in middle-high income, non-migrant, urban women (reference group). Women had a lower risk of mortality than men regardless of annual gross income, migration status and residence area. Migrants’ mortality risk varied depending on socioeconomic situation. All models had a large discriminatory accuracy, which increased across the intersectional analysis. Conclusions There is a clear association between SDH and mortality in patients with multimorbidity. The intersectional approach used in this study revealed some interactions among these determinants, illustrating the social disadvantage that underlies the need to implement policies to promote equitable health promotion.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Training needs and curricular priorities for managing multimorbidity in Spanish primary care: findings from a national exploratory online survey

  • Leiva-Fernández, Francisca
  • González-Hevilla, Alba
  • Castillo-Jimena, Marcos
  • Moreno-Juste, Aida
  • López-Rodríguez, Juan Antonio
  • Ara-Bardají, Paula
  • del Cura-González, Isabel
  • Gimeno-Miguel, Antonio
  • Abad-Díez, José María
  • Alcaraz Borrajo, Marta
  • Ariza Cardiel, Gloria
  • Aza-Pascual-Salcedo, Mercedes
  • Azcoaga Lorenzo, Amaya
  • Bandrés-Liso, Ana Cristina
  • del Pilar Barnestein-Fonseca, Maria
  • Cardiel, María Bestué
  • Bliek Bueno, Kevin
  • Bujalance-Zafra, María José
  • Calderon-Larrañaga, Amaia
  • Cano del Pozo, Mabel
  • Carmona Pirez, Jonas
  • Carrión de la Fuente, María Teresa
  • Clerencia-Sierra, Mercedes
  • Díez Manglano, Jesús
  • Fuentes Ruiz, Jose Ángel
  • González González, Ana Isabel
  • González Rubio, Francisca
  • Guerrero Fernández de Alba, Inmaculada
  • Ioakeim Skoufa, Ignatios
  • López-Verde, Fernando
  • et al
Background Multimorbidity is highly prevalent and poses clinical and organisational challenges, yet the training of doctors and nurses continues to focus mainly on single conditions. In recent years, training interventions for healthcare professionals on multimorbidity have emerged, but evidence of their effectiveness remains limited. Understanding the learning needs of professionals is essential for guiding educational programmes. This study aimed to identify the perceived training needs of primary care physicians and nurses in the management of multimorbidity and to contribute to a proposal of updated curriculum content. Methods Exploratory cross-sectional study using an online survey of doctors and nurses in primary care and out-of-hospital emergency services in Spain. The questionnaire was developed based on the literature, existing curriculum frameworks and previous findings from the MULTIPAP study, and collected sociodemographic, professional and educational data, as well as perceptions about resources, difficulties and training needs in multimorbidity. Descriptive, bivariate, and multivariable analyses were conducted, and open-ended responses were analysed using thematic content analysis. Results The main difficulties and training needs concerned medicines management and diagnostic and therapeutic challenges, followed by communication and time management. Participants valued patient–caregiver-centred care, medicines management, and care coordination. An online format with videos was preferred. Differences were observed by profession, gender, field of work, trainee status, and prior participation in the MULTIPAP study. The proposed curriculum comprised eight competency groups, including professionalism and social sciences along with other key issues, especially clinical, communication, and management skills. Conclusion Professionals share many training needs, obstacles, and resources related to multimorbidity care, with some differences between subgroups. These findings informed a proposal for an updated curriculum content.
Docta Complutense
Publication Artículo científico (JournalArticle)

Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty

  • Diaz-Ruiz, Raquel
  • Poca, Maria
  • Roman, Eva
  • Cuyas, Berta
  • Bañares, Irene
  • Morales, Angela
  • Hernandez Martinez-Esparza, Elvira
  • Panadero, Rocio
  • Velasco, Cristina
  • Rapado Castro, Marta
  • Bretón Lesmes, Irene
  • Bañares Cañizares, Rafael
  • Soriano, German
  • García Martínez, Rita
Abstract: Background/aim: Frailty is increasingly recognized as a relevant prognostic factor in patients with cirrhosis, regardless of liver failure. Vitamin D deficiency is frequent in these patients and has been related to frailty and sarcopenia, but the impact of its supplementation on frailty in cirrhosis is unknown. The aim was to evaluate the effect of vitamin D supplementation on frailty in patients with decompensated cirrhosis and vitamin D deficiency or insufficiency. Methods: We included patients with cirrhosis who had vitamin D deficiency or insufficiency following their hospitalization for acute decompensation. Vitamin D was supplemented according to current recommendations, as were other micronutrients if necessary. Patients were followed for one year to evaluate changes at 6 and 12 months in frailty (Fried frailty index), health-related quality of life (SF-36, CLDQ) and mood (HADS). Body composition was assessed by DXA at baseline and at 12 months. Results: We included 39 patients, 27 of whom reached the 6-month follow-up. Serum vitamin D increased at 6 and 12 months (p < 0.001 compared to baseline). Fried frailty index improved at the 6-month visit (p = 0.004), and handgrip strength improved at 6 (p = 0.001) and 12 (p = 0.002) months, similarly in women and men. At 12 months, we observed an increase in body mass index, right arm lean mass and total fat mass. Conclusions: A multifactorial nutritional intervention, especially vitamin D supplementation after discharge in decompensated, vitamin D-deficient patients with cirrhosis, was associated with an improvement in frailty, muscular strength and lean muscle mass. However, the increase in fat mass strengthens the recommendation for diet, exercise and weight supervision.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MacroH2A1.1 regulates mitochondrial respiration by limiting nuclear NAD + consumption

  • Posavec Marjanović, Melanija
  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Lassi, Maximilian
  • Valero, Vanesa
  • Malinverni, Roberto|||0000-0002-0113-3417
  • Delage, Hélène
  • Navarro, Miriam
  • Corujo, David|||0000-0001-7930-0935
  • Guberovic, Iva
  • Douet, Julien
  • Gama-Pérez, Pau
  • Garcia-Roves, Pablo M.|||0000-0001-9826-1740
  • Ahel, Ivan
  • Ladurner, Andreas G.|||0000-0003-3835-232X
  • Yanes, Oscar|||0000-0003-3695-7157
  • Bouvet, Philippe|||0000-0003-4524-2233
  • Suelves Esteban, Mònica|||0000-0001-7095-5804
  • Teperino, Raffaele
  • Pospisilik, J. Andrew
  • Buschbeck, Marcus|||0000-0002-3218-4567
Histone variants are structural components of eukaryotic chromatin that can replace replication-coupled histones in the nucleosome. The histone variant macroH2A.1.1 contains a macrodomain able to bind NAD + derived metabolites. Here, we report that macroH2A.1.1 is rapidly induced during myogenic differentiation through a switch in alternative splicing. Importantly, myotubes lacking macroH2A.1.1 display a defect in mitochondrial respiratory capacity. We find that the metabolite-interacting macrodomain is essential for sustaining optimal mitochondrial function, but dispensable for gene regulation. Through direct binding, macroH2A.1.1 inhibits basal poly-ADP ribose polymerase 1 activity and thus reduces nuclear NAD+ consumption. Consequentially, accumulation of the NAD + precursor NMN allows the maintenance of mitochondrial NAD + pools critical for respiration. Our data indicate that macroH2A.1.1-containing chromatin regulates mitochondrial respiration by limiting nuclear NAD+ consumption and establishing a buffer of NAD + precursors in differentiated cells.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Calorie restriction prevents diet-induced insulin resistance independently of PGC-1-driven mitochondrial biogenesis in white adipose tissue

  • Pardo, Rosario
  • Vilà, María|||0000-0003-0286-3961
  • Cervela-Cardona, Luis|||0000-0002-7293-4473
  • De Marco, Marina
  • Gama-Pérez, Pau
  • González-Franquesa, A.
  • Statuto, Lucia
  • Vilallonga, Ramon|||0000-0001-9333-2765
  • Simó, Rafel
  • Garcia-Roves, Pablo M.|||0000-0001-9826-1740
  • Villena, Josep A.|||0000-0002-2200-2985
Calorie restriction (CR) exerts remarkable, beneficial effects on glucose homeostasis bymechanisms that are not fully understood. Given the relevance of white adipose tissue (WAT) in glucose homeostasis, we aimed at identifying the main cellular processes regulated inWAT in response to CR in a pathologic context of obesity. For this, a gene-expression profiling studywas first conducted inmice fed ad libitum or subjected to 40%CR.We found that the genenetwork relatedtomitochondriawas themosthighlyupregulatedinWATbyCR.To study the role that increased mitochondrial biogenesis plays on glucose homeostasis following CR, we generated a mouse model devoid of the coactivators peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1)a and PGC-1b specificallyinadipocytes. Our results showthatmice lackingPGC-1s inadipocytes areunable to increase mitochondrial biogenesis in WAT upon CR. Despite a blunted induction of mitochondrial biogenesis in response to calorie deprivation, mice lacking adipose PGC-1s still respond to CR by improving their glucose homeostasis. Our study demonstrates that PGC-1 coactivators are major regulators of CR-induced mitochondrial biogenesis in WAT and that increased mitochondrial biogenesis and oxidative function in adipose tissue are not required for the improvement of glucose homeostasismediated byCR.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

  • García Gómez, Antonio
  • Li, Tianlu|||0000-0001-7152-4870
  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ciudad, Laura|||0000-0002-5219-6792
  • Català-Moll, Francesc|||0000-0002-2354-8648
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Martín Sánchez, Montserrat
  • San Segundo, Laura|||0000-0003-2391-5935
  • Muntión, Sandra|||0000-0001-7164-0767
  • Morales Urteaga, Xabier|||0000-0003-0303-9958
  • Ortiz de Solórzano, Carlos|||0000-0001-8720-0205
  • Oyarzabal, Julen|||0000-0003-1941-7255
  • San José Enériz, Edurne|||0000-0001-5786-5273
  • Esteller, M|||0000-0003-4490-6093
  • Agirre, Xabier|||0000-0002-6558-9560
  • Prosper, Felipe|||0000-0001-6115-8790
  • Garayoa, Mercedes|||0000-0003-2194-2841
  • Ballestar, Esteban|||0000-0002-1400-2440
Multiple myeloma (MM) progression and myeloma-associated bone disease (MBD) are highly dependent on bone marrow mesenchymal stromal cells (MSCs). MM-MSCs exhibit abnormal transcriptomes, suggesting the involvement of epigenetic mechanisms governing their tumor-promoting functions and prolonged osteoblast suppression. Here, we identify widespread DNA methylation alterations of bone marrow-isolated MSCs from distinct MM stages, particularly in Homeobox genes involved in osteogenic differentiation that associate with their aberrant expression. Moreover, these DNA methylation changes are recapitulated in vitro by exposing MSCs from healthy individuals to MM cells. Pharmacological targeting of DNMTs and G9a with dual inhibitor CM-272 reverts the expression of hypermethylated osteogenic regulators and promotes osteoblast differentiation of myeloma MSCs. Most importantly, CM-272 treatment prevents tumor-associated bone loss and reduces tumor burden in a murine myeloma model. Our results demonstrate that epigenetic aberrancies mediate the impairment of bone formation in MM, and its targeting by CM-272 is able to reverse MBD.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Assessment of minimal residual disease by next generation sequencing in peripheral blood as a complementary tool for personalized transplant monitoring in myeloid neoplasms

  • Aguirre-Ruiz, Paula
  • Ariceta, Beñat
  • Viguria Alegría, María Cruz
  • Zudaire, María Teresa
  • Blasco-Iturri, Zuriñe
  • Arnedo, Patricia
  • Aguilera-Diaz, Almudena
  • Jauregui, Axier
  • Mañú, Amagoia
  • Prósper, Felipe
  • Mateos, María Carmen
  • Fernández-Mercado, Marta
  • Larráyoz, María José
  • Redondo, Margarita
  • Calasanz, María José
  • Bandrés Elizalde, Eva
  • Vázquez Urio, Iria
Patients with myeloid neoplasms who relapsed after allogenic hematopoietic stem cell transplant (HSCT) have poor prognosis. Monitoring of chimerism and specific molecular markers as a surrogate measure of relapse is not always helpful; therefore, improved systems to detect early relapse are needed. We hypothesized that the use of next generation sequencing (NGS) could be a suitable approach for personalized follow-up post-HSCT. To validate our hypothesis, we analyzed by NGS, a retrospective set of peripheral blood (PB) DNA samples previously evaluated by high-sensitive quantitative PCR analysis using insertion/deletion polymorphisms (indel-qPCR) chimerism engraftment. Post-HCST allelic burdens assessed by NGS and chimerism status showed a similar time-course pattern. At time of clinical relapse in 8/12 patients, we detected positive NGS-based minimal residual disease (NGS-MRD). Importantly, in 6/8 patients, we were able to detect NGS-MRD at time points collected prior to clinical relapse. We also confirmed the disappearance of post-HCST allelic burden in non-relapsed patients, indicating true clinical specificity. This study highlights the clinical utility of NGS-based post-HCST monitoring in myeloid neoplasia as a complementary specific analysis to high-sensitive engraftment testing. Overall, NGS-MRD testing in PB is widely applicable for the evaluation of patients following HSCT and highly valuable to personalized early treatment intervention when mixed chimerism is detected., This work was funded by the Government of Navarra, Department of Industry, Energy and Innovation (Project DIANA, 0011-1411-2017-000028); and supported by CIMA LAB diagnostics research program. F.P. acknowledges funding from Instituto de Salud Carlos III (ISCIII) PI16/02024, PI17/00701 and PI19/01352 (Co-financed with European Union FEDER funds), CIBERONC CB16/12/00489 (Co-financed with European Union FEDER funds), MINECO Explora (RTHALMY), Departamento de Salud-Gobierno de Navarra 40/2016 and Fundación Ramón Areces (PREMAMM).